Received Dec 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Y011819 | OT |
No additional AE; A patient received an expired CAPVAXIVE on 11/6/2025; This spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history, past medications, concurrent conditions, and concomitant medications were not reported. On 06-Nov-2025, the patient was vaccinated with an expired dose of Pneumococcal 21-valent Conjugate Vaccine Solution for injection (CAPVAXIVE) 1 dosage form, total (valid lot number: Y011819, expiration date reported and confirmed as 01-Oct-2025; exact dose, route of administration, and anatomical location were not reported) as prophylaxis. No additional adverse events reported (no adverse event).